Lung failure therapies
novalung is the world‘s first lung failure therapy platform, which competes favorably against one-product offerings. The novalung product family enables therapies for lung failure that are adapted to specific indications. In addition, novalung products’ smaller cannulas lower the threshold for adoption. In short, novalung products can replace or reduce invasive mechanical ventilation with therapies tailored to the needs of each patient. The novalung platform performs any level of CO2 removal and oxygenation in acute respiratory failure / AECOPD.
“Novalung’s lung support therapies can be dosed as required in order to individualize to a patient’s specific needs, which is a very significant clinical benefit.”
Thomas Bein, MD
University of Regensburg, Medical Center